Boutique Diagnostics

Digital Health Market Access Consulting Firm

Digital Health Solutions

HTA

Access relevant diagnostics scientific publications – 2022 March

Access relevant diagnostics scientific publications – 2022 March

Exciting, selected scientific publications from the world of (digital) diagnostics from market access, health care systems, policy, and clinical value perspectives.

Access relevant diagnostics scientific publications – 2022 February

Access relevant diagnostics scientific publications – 2022 February

Exciting, selected scientific publications from the world of (digital) diagnostics from market access, health care systems, policy, and clinical value perspectives.

July 2021: What’s new in the world of diagnostics?

July 2021: What’s new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

10 most exciting (digital) diagnostics news from 2019

10 most exciting (digital) diagnostics news from 2019

The top/best/most lists are always subjective, so is ours. Looking back to 2019 we enjoyed reading the following 10 news bites the most. This inventory is far from being comprehensive, yet they can point to broader trends.

Payer Trends in Diagnostics & Digital Health – What’s new?

Payer Trends in Diagnostics & Digital Health – What’s new?

Last year we released a blog post on 5 recent Payer trends in Diagnostics. What are the latest developments? Check out this short summary:

  1. Growing appetite for diagnostics health technology assessment in Europe

  2. Joint (regulator-payer) evidence reviews and scientific advice to MedTech manufacturers gain further momentum in the US

  3. Payers start to embrace Digital Health

3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access

3+1 Policy Initiatives That Will Influence Diagnostics (IVD) Access

The diagnostics industry is facing increasing policy attention. Policymakers push for broader access, better affordability and safer than ever solutions. Institutions, like the European Union (EU) and World Health Organization (WHO), are involved in introducing new regulations.

Find out what are the latest policy initiatives and how will they impact access for IVD solutions.

Five Diagnostics (IVD) Access Challenges & Potential Actions

Five Diagnostics (IVD) Access Challenges & Potential Actions

Five Diagnostics (IVD) Access Challenges & Potential Actions:

  1. Diagnostics are complex solutions

  2. Less clinical investment

  3. Cost-based reimbursement

  4. Lack of clear funding processes and guidelines

  5. Limited-use cases in digital diagnostics reimbursement

CENTIVIS awarded ‘Approved Facilitator’ status for NICE META Tool

CENTIVIS awarded ‘Approved Facilitator’ status for NICE META Tool

CENTIVIS awarded ‘Approved Facilitator’ status for latest NICE META Tool

CENTIVIS has recently been approved by NICE (National Institute for Health and Care Excellence) as one of the limited number of qualified Medtech Early Technical Assessment (META) Tool facilitators.

NICE has developed the META tool to help medical technology developers understand what evidence is needed to make a convincing case to payers and commissioners.

"With NICE META tool our diagnostics and digital health clients will benefit from a structured, streamlined and affordable evidence review to better capture the value of their diagnostic and digital health solutions"

Do you want to know more? SCHEDULE A CALL or visit the product page

Norbert